ECG
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Financial indicators Supports a bullish reading. Current ratio 1.76 · operating margin 7.1%
- Narrative Supports a bullish reading. Stored narrative reading is in the bullish band
- Timing Unavailable or mixed. No stored price series
ACHAT TOTAL: 1 000 titres (~144 950,00 $ US)
- Insiders
- SPARBY DAVID M
- Total bought
-
$144,950
Avg buy (VWAP, 90d window) $144.95 vs last close —
- Total sold
-
—
Avg sell (VWAP, 90d window) $136.69 vs last close —
- Last activity
- 2026-08-17
- Last synced
-
2026-08-23 00:12:53
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-17 | SPARBY DAVID M | Buy | 1,000 | $144.95 | $144,950 | Form 4 |
| 2026-08-07 | Sanderson Paul R. | Sell | 3,300 | $136.69 | $451,077 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bullish signalScored 2026-08-26
ECG presents a compelling event-driven setup anchored by a strong Q2 2026 earnings beat (44% above estimates), raised FY2026 guidance, and surging estimate revisions, all reinforced by insider buying and new…
The first sentence of the analysis written for ECG on 2026-08-26 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 12.1% | 11.9% | 11.3% | 10.2% | 12.1% | |
| Ebit Margin | 7.9% | 6.8% | 6.5% | 6.2% | 7.2% | |
| Ebitda Margin | 8.7% | 7.7% | 7.3% | 6.9% | 8.2% | |
| Operating Profit Margin | 7.1% | 6.7% | 6.7% | 6.1% | 7.1% | |
| Pretax Profit Margin | 7.3% | 6.8% | 6.4% | 6.1% | 7.1% | |
| Continuous Operations Profit Margin | 5.4% | 5.0% | 4.8% | 4.6% | 5.3% | |
| Net Profit Margin | 5.4% | 5.0% | 4.8% | 4.6% | 5.3% | |
| Bottom Line Profit Margin | 5.4% | 5.0% | 4.8% | 4.6% | 5.3% | |
| Current Ratio | 1.761 | 1.787 | 1.851 | 1.664 | 0.000 | |
| Quick Ratio | 1.699 | 1.701 | 1.742 | 1.586 | 0.000 | |
| Solvency Ratio | 0.210 | 0.195 | 0.266 | 0.194 | 0.000 | |
| Cash Ratio | 0.232 | 0.168 | 0.004 | 0.004 | 0.000 | |
| Price To Earnings Ratio | 21.716 | 23.399 | 18.216 | 20.000 | 22.791 | |
| Price To Earnings Growth Ratio | 0.540 | 5.245 | 1.860 | 1.433 | 0.000 | |
| Forward Price To Earnings Growth Ratio | 0.540 | 5.245 | 1.860 | 1.433 | 0.000 | |
| Price To Earnings Diluted Ratio | 21.661 | 23.399 | 18.216 | 20.000 | 22.791 | |
| Price To Earnings Diluted Growth Ratio | 0.534 | 5.245 | 1.860 | 1.433 | 0.000 | |
| Price To Book Ratio | 6.935 | 7.930 | 5.565 | 6.534 | 0.000 | |
| Price To Sales Ratio | 1.166 | 1.176 | 0.875 | 0.925 | 1.217 | |
| Price To Free Cash Flow Ratio | 48.528 | 29.118 | 18.399 | -40.718 | 42.940 | |
| Price To Operating Cash Flow Ratio | 27.849 | 20.514 | 14.577 | -97.965 | 29.229 | |
| Debt To Assets Ratio | 0.215 | 0.282 | 0.211 | 0.269 | 0.000 | |
| Debt To Equity Ratio | 0.591 | 0.859 | 0.495 | 0.798 | 0.000 | |
| Debt To Capital Ratio | 0.371 | 0.462 | 0.331 | 0.444 | 0.000 | |
| Long Term Debt To Capital Ratio | 0.297 | 0.399 | 0.273 | 0.370 | 0.000 | |
| Financial Leverage Ratio | 2.745 | 3.049 | 2.345 | 2.971 | 0.000 | |
| Working Capital Turnover Ratio | 7.772 | 7.711 | 8.787 | 0.000 | 0.000 | |
| Operating Cash Flow Ratio | 0.213 | 0.318 | 0.435 | -0.054 | 0.000 | |
| Operating Cash Flow Sales Ratio | 0.042 | 0.057 | 0.060 | -0.009 | 0.042 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.574 | 0.704 | 0.792 | 2.406 | 0.681 | |
| Debt Service Coverage Ratio | 6.914 | 5.876 | 5.818 | 4.398 | 0.000 | |
| Interest Coverage Ratio | 12.342 | 13.543 | 6.833 | 25.912 | 41.173 | |
| Short Term Operating Cash Flow Coverage Ratio | 10.456 | 10.892 | 0.000 | -0.944 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.422 | 0.450 | 0.771 | -0.084 | 0.000 | |
| Capital Expenditure Coverage Ratio | 2.347 | 3.384 | 4.814 | -0.711 | 3.132 | |
| Dividend Paid And Capex Coverage Ratio | 2.347 | 3.384 | 4.814 | -0.711 | 3.132 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 14.089 | 16.490 | 13.100 | 14.938 | 0.000 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 12.1% | ▲0.2% | ▲0.6% |
| Ebit Margin | 7.9% | ▲1.1% | ▲1.0% |
| Ebitda Margin | 8.7% | ▲0.9% | ▲0.9% |
| Operating Profit Margin | 7.1% | ▲0.4% | ▲0.3% |
| Pretax Profit Margin | 7.3% | ▲0.5% | ▲0.6% |
| Continuous Operations Profit Margin | 5.4% | ▲0.4% | ▲0.4% |
| Net Profit Margin | 5.4% | ▲0.4% | ▲0.4% |
| Bottom Line Profit Margin | 5.4% | ▲0.4% | ▲0.4% |
| Current Ratio | 1.761 | ▼-0.026 | ▲0.348 |
| Quick Ratio | 1.699 | ▼-0.002 | ▲0.354 |
| Solvency Ratio | 0.210 | ▲0.015 | ▲0.037 |
| Cash Ratio | 0.232 | ▲0.064 | ▲0.150 |
| Price To Earnings Ratio | 21.716 | ▼-1.683 | ▲0.492 |
| Price To Earnings Growth Ratio | 0.540 | ▼-4.705 | ▼-1.276 |
| Forward Price To Earnings Growth Ratio | 0.540 | ▼-4.705 | ▼-1.276 |
| Price To Earnings Diluted Ratio | 21.661 | ▼-1.738 | ▲0.448 |
| Price To Earnings Diluted Growth Ratio | 0.534 | ▼-4.711 | ▼-1.280 |
| Price To Book Ratio | 6.935 | ▼-0.995 | ▲1.542 |
| Price To Sales Ratio | 1.166 | ▼-0.010 | ▲0.094 |
| Price To Free Cash Flow Ratio | 48.528 | ▲19.409 | ▲28.874 |
| Price To Operating Cash Flow Ratio | 27.849 | ▲7.335 | ▲29.008 |
| Debt To Assets Ratio | 0.215 | ▼-0.067 | ▲0.020 |
| Debt To Equity Ratio | 0.591 | ▼-0.269 | ▲0.042 |
| Debt To Capital Ratio | 0.371 | ▼-0.091 | ▲0.050 |
| Long Term Debt To Capital Ratio | 0.297 | ▼-0.102 | ▲0.030 |
| Financial Leverage Ratio | 2.745 | ▼-0.304 | ▲0.523 |
| Working Capital Turnover Ratio | 7.772 | ▲0.061 | ▲2.918 |
| Operating Cash Flow Ratio | 0.213 | ▼-0.105 | ▲0.031 |
| Operating Cash Flow Sales Ratio | 0.042 | ▼-0.015 | ▲0.004 |
| Free Cash Flow Operating Cash Flow Ratio | 0.574 | ▼-0.131 | ▼-0.458 |
| Debt Service Coverage Ratio | 6.914 | ▲1.038 | ▲2.313 |
| Interest Coverage Ratio | 12.342 | ▼-1.200 | ▼-7.619 |
| Short Term Operating Cash Flow Coverage Ratio | 10.456 | ▼-0.435 | ▲6.376 |
| Operating Cash Flow Coverage Ratio | 0.421 | ▼-0.028 | ▲0.110 |
| Capital Expenditure Coverage Ratio | 2.347 | ▼-1.037 | ▼-0.246 |
| Dividend Paid And Capex Coverage Ratio | 2.347 | ▼-1.037 | ▼-0.246 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 14.089 | ▼-2.401 | ▲2.366 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $4.37B | $3.35B | $2.50B | $2.50B | $2.50B | |
| Enterprise value | $4.57B | $3.63B | $2.72B | $2.80B | $0 | |
| EV / Sales | 1.22x | 1.27x | 0.95x | 1.04x | 0.00x | |
| EV / Op. cash flow | 29.13x | 22.21x | 15.87x | -109.85x | 0.00x | |
| EV / Free cash flow | 50.77x | 31.53x | 20.02x | -45.66x | 0.00x | |
| EV / EBITDA | 14.09x | 16.49x | 13.10x | 14.94x | 0.00x | |
| Net debt / EBITDA | 0.62x | 1.26x | 1.06x | 1.62x | 0.00x | |
| Current ratio | 1.76x | 1.79x | 1.85x | 1.66x | 0.00x | |
| Income quality | 0.78x | 1.14x | 1.25x | -0.20x | 0.78x | |
| Graham number | $33 | $23 | $23 | $20 | $0 | |
| Graham net-net | -$3 | -$4 | -$2 | -$4 | $0 | |
| Tax burden | 73.6% | 74.3% | 75.2% | 75.4% | 75.5% | |
| Interest burden | 92.7% | 99.1% | 99.0% | 99.7% | 98.2% | |
| Working capital | $560.2M | $403.9M | $335.2M | $314.4M | $0 | |
| Invested capital | $960.6M | $748.7M | $649.7M | $625.0M | $0 | |
| Return on assets | 11.7% | 11.1% | 13.0% | 11.0% | 0.0% | |
| Operating ROA | 17.5% | 16.2% | 17.4% | 0.0% | 0.0% | |
| Return on tangible assets | 12.7% | 12.5% | 15.1% | 12.6% | 0.0% | |
| Return on equity | 32.0% | 33.9% | 30.6% | 32.6% | 0.0% | |
| Return on invested capital | 18.7% | 17.3% | 21.1% | 17.5% | 0.0% | |
| Return on capital employed | 26.7% | 24.5% | 28.9% | 24.9% | 0.0% | |
| Earnings yield | 4.6% | 4.3% | 5.5% | 5.0% | 4.4% | |
| Free cash flow yield | 2.1% | 3.4% | 5.4% | -2.5% | 2.3% | |
| Capex / Op. cash flow | 42.6% | 29.6% | 20.8% | -140.6% | 31.9% | |
| Capex / Depreciation | 232.1% | 191.0% | 153.7% | 167.0% | 134.6% | |
| Capex / Sales | 1.8% | 1.7% | 1.2% | 1.3% | 1.3% | |
| SG&A / Sales | 5.1% | 5.2% | 3.8% | 4.1% | 5.0% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.2% | 0.1% | 0.0% | 0.0% | 0.1% | |
| Intangibles / Total assets | 8.3% | 11.1% | 13.8% | 13.0% | 0.0% | |
| Days sales outstanding | 100d | 97d | 85d | 100d | 0d | |
| Days payables outstanding | 25d | 20d | 17d | 21d | 0d | |
| Operating cycle | 105d | 103d | 91d | 105d | 0d | |
| Cash conversion cycle | 80d | 83d | 75d | 84d | 0d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent news
- 2026-08-22 BlackRock Inc. Acquires Shares of 6,593,812 Everus Construction Group, Inc. $ECG BlackRock Inc. acquired a new position in Everus Construction Group, Inc. (NYSE: ECG) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 6,593,812 shares of the company''s stock, valued at approximately $1,094,243,000. BlackRock Inc. owned approximately 12.92%
- 2026-08-18 Wasatch U.S. Select Fund Q2 2026 Portfolio Update The Wasatch U.S. Select Fund - Investor Class returned 12.46%, trailing the Russell 2500 Growth Index, which gained 24.02% during the quarter. While the market environment favoring low-quality companies was a large reason for our relative underperformance, we also held stocks that lost ground in the period, and that too weighed on relative results. The largest of the detractors was Ensign Group, an operator of skilled-nursing and senior-living facilities.
- 2026-08-17 Surging Earnings Estimates Signal Upside for Everus Construction Group, Inc. (ECG) Stock Everus Construction Group, Inc. (ECG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 2026-08-13 Use DuPont Analysis to Pick 5 Top-Ranked Quality Stocks Do you have more faith in DuPont analysis than simple ROE? 5 top-ranked stocks -- CNXN, ECG, BLBD, EXPD and VLO -- stand out on profitability, asset efficiency and leverage scores.
- 2026-08-10 Can Everus Construction Group, Inc. (ECG) Climb 25.16% to Reach the Level Wall Street Analysts Expect? The consensus price target hints at a 25.2% upside potential for Everus Construction Group, Inc. (ECG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- 2026-08-08 Everus Construction Group Q2 Earnings Call Highlights Everus Construction Group NYSE: ECG reported record second-quarter revenue and EBITDA as demand remained strong across its electrical and mechanical, or E&M, and transmission and distribution, or T&D, businesses. The company also raised its full-year 2026 revenue and EBITDA guidance following what CEO Jeff Thiede described as sustained market demand, strong project execution and robust backlog growth.
- 2026-08-06 California State Teachers Retirement System Purchases 10,726 Shares of Everus Construction Group, Inc. $ECG California State Teachers Retirement System lifted its position in shares of Everus Construction Group, Inc. (NYSE: ECG) by 23.1% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 57,084 shares of the company''s stock after buying an additional 10,726 shares during the
- 2026-08-05 Impressive Quarter Highlights Ongoing Strengths In Everus Construction Group (Upgrade) Everus Construction Group delivered a standout Q2 2026, with GAAP EPS of $1.64, beating estimates by 44% and driving the stock up 6%. ECG raised FY 2026 revenue and EBITDA guidance, fueled by robust data center demand, strong execution, and a 41% YoY backlog increase to $4.55 billion. Recent acquisitions (Epsilon Industries, SE&M Constructors) expand ECG''s modular and MEP capabilities, while net debt remains conservative at $120 million (0.3x leverage).
- 2026-08-05 Wasatch Long/Short Alpha Fund Q2 2026 Contributors And Detractors The Wasatch Long/Short Alpha Fund - Investor Class did not keep pace and finished the period up 8.29%. The largest detractor among our long positions was Ensign Group, an operator of skilled nursing and senior living facilities. The top contributor to Fund performance was JFrog Ltd.
- 2026-08-05 Everus Construction Group, Inc. (ECG) Q2 2026 Earnings Call Transcript Everus Construction Group, Inc. (ECG) Q2 2026 Earnings Call Transcript